ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

OPRX OptimizeRx Corporation

10.62
-0.08 (-0.75%)
May 03 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 103,033
Bid Price 8.78
Ask Price 11.04
News -
Day High 10.97

Low
6.92

52 Week Range

High
16.645

Day Low 10.60
Share Name Share Symbol Market Stock Type
OptimizeRx Corporation OPRX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.08 -0.75% 10.62 15:30:00
Open Price Low Price High Price Close Price Previous Close
10.94 10.60 10.97 10.62 10.70
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
2,002 103,033 US$ 10.71 US$ 1,103,032 - 6.92 - 16.645
Last Trade Type Quantity Price Currency
16:29:52 5 US$ 10.83 USD

OptimizeRx Corporation Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
192.42M 18.15M - 71.52M -17.57M -0.97 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

OptimizeRx News

Date Time Source News Article
3/11/202416:04Edgar (US Regulatory)Form 8-K - Current report
3/06/202415:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/21/202417:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/21/202417:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/21/202417:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/21/202417:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/14/202416:05Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial..
2/13/202417:16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
1/26/202415:00Edgar (US Regulatory)Form 8-K - Current report
1/11/202416:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
1/09/202415:28Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
1/05/202416:19Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No OPRX Message Board. Create One! See More Posts on OPRX Message Board See More Message Board Posts

Historical OPRX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week9.5210.979.4110.21206,6691.1011.55%
1 Month11.1311.698.4359.93151,865-0.51-4.58%
3 Months15.6016.6458.43512.22135,573-4.98-31.92%
6 Months8.3416.6458.3211.99152,1622.2827.34%
1 Year14.7916.6456.9211.25147,986-4.17-28.19%
3 Years50.5499.17776.9233.64201,444-39.92-78.99%
5 Years10.4499.17776.501931.08178,4690.181.72%

OptimizeRx Description

OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution support patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its products offering are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.

Your Recent History

Delayed Upgrade Clock